Four stock-moving events to watch as FDA revives AdComs
Seeking Alpha ·
The Advisory Committee meetings, a key regulatory step in U.S. drug and MedTech approvals, are making a comeback as the Food and Drug Administration seeks to revisit several controversial decisions made under the former commissioner, Marty Makary.
DYAX Investor Sentiment
Bullish (Long) 62% · Bearish (Short) 38%
311 participants
Related News
- Inogen appoints Andy Reding as chief operating officer
- Actelis secures $0.85M software and services contract
- Global-E Online closes on Passport acquisition as it adds to its shipping capabilities
- Palantir CEO speaks out against 'tokenmaxxing' being pushed by frontier labs
- Columbus McKinnon appoints new CFO
- Netflix gains over 3% as report refutes NBCUniversal acquisition speculation